Patel DD - Search Results

1

Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.

Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Ghosh N, Chikhlikar PR, Trivedi TI. Bhatavdekar JM, et al. Among authors: patel dd. Eur J Surg Oncol. 2000 Sep;26(6):540-7. doi: 10.1053/ejso.2000.0943. Eur J Surg Oncol. 2000. PMID: 11034803

2

Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.

Bhatavdekar JM, Patel DD, Giri DD, Karelia NH, Vora HH, Ghosh N, Shah NG, Trivedi SN, Balar DB. Bhatavdekar JM, et al. Among authors: patel dd. Br J Cancer. 1992 Nov;66(5):977-80. doi: 10.1038/bjc.1992.395. Br J Cancer. 1992. PMID: 1419646 Free PMC article.

3

Plasma prolactin as an indicator of disease progression in advanced breast cancer.

Bhatavdekar JM, Shah NG, Balar DB, Patel DD, Bhaduri A, Trivedi SN, Karelia NH, Ghosh N, Shukla MK, Giri DD. Bhatavdekar JM, et al. Among authors: patel dd. Cancer. 1990 May 1;65(9):2028-32. doi: 10.1002/1097-0142(19900501)65:9<2028::aid-cncr2820650924>3.0.co;2-9. Cancer. 1990. PMID: 2372769

4

Comparison of prolactin, CA 15-3 and TPA in breast carcinomas.

Bhatavdekar JM, Trivedi SN, Shah NG, Patel DD, Karelia NH, Shukla MK, Ghosh N, Vora HH. Bhatavdekar JM, et al. Among authors: patel dd. Int J Biol Markers. 1989 Jul-Sep;4(3):150-6. doi: 10.1177/172460088900400304. Int J Biol Markers. 1989. PMID: 2614083

5

Circulating prolactin and TPS in monitoring the clinical course of male patients with metastatic tongue cancer: a preliminary study.

Bhatavdekar JM, Patel DD, Vora HH, Balar DB. Bhatavdekar JM, et al. Among authors: patel dd. Anticancer Res. 1993 Jan-Feb;13(1):237-40. Anticancer Res. 1993. PMID: 7682801

6

Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin.

Bhatavdekar JM, Patel DD, Shah NG, Karelia NH, Vora HH, Ghosh N, Suthar TP, Balar DB. Bhatavdekar JM, et al. Among authors: patel dd. Eur J Surg Oncol. 1995 Feb;21(1):23-6. doi: 10.1016/s0748-7983(05)80062-9. Eur J Surg Oncol. 1995. PMID: 7851547

7

Prolactin: its role in advanced tongue cancer.

Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Karelia NH, Ghosh N, Balar DB. Bhatavdekar JM, et al. Among authors: patel dd. J Surg Oncol. 1994 Oct;57(2):115-20. doi: 10.1002/jso.2930570209. J Surg Oncol. 1994. PMID: 7934062

8

Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study.

Bhatavdekar JM, Patel DD, Karelia NH, Vora HH, Ghosh N, Shah NG, Balar DB, Trivedi SN. Bhatavdekar JM, et al. Among authors: patel dd. Breast Cancer Res Treat. 1994;30(3):293-7. doi: 10.1007/BF00665970. Breast Cancer Res Treat. 1994. PMID: 7981447

9

Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein.

Bhatavdekar JM, Patel DD, Sherbet GV, Giri DD, Karelia NH, Vora HH, Shah NG, Suthar TP, Nadkarni SP, Balar DB. Bhatavdekar JM, et al. Among authors: patel dd. Eur J Surg Oncol. 1993 Oct;19(5):409-13. Eur J Surg Oncol. 1993. PMID: 8104829

10

Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?

Bhatavdekar JM, Patel DD, Karelia NH, Shah NG, Ghosh N, Vora HH, Suthar TP, Balar DB, Doctor SS. Bhatavdekar JM, et al. Among authors: patel dd. Eur J Surg Oncol. 1994 Apr;20(2):118-21. Eur J Surg Oncol. 1994. PMID: 8181575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page